Spots Global Cancer Trial Database for erwinia asparaginase

Every month we try and update this database with for erwinia asparaginase cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma	NCT01451515	Lymphoblastic L...	Prednisone Vincristine Daunorubicin PEG-asparaginas... Erwinia asparag... Doxorubicin Cyclophosphamid... Cytarabine Thioguanine Clofarabine Methotrexate Mercaptopurine Dexamethasone Hydrocortisone Etoposide	- 21 Years	St. Jude Children's Research Hospital
Venetoclax Basket Trial for High Risk Hematologic Malignancies	NCT05292664	Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ...	Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag...	1 Year - 40 Years	Dana-Farber Cancer Institute
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents	NCT03020030	Acute Lymphobla...	Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine	1 Year - 21 Years	Dana-Farber Cancer Institute
A Study of Children With Refractory or Relapsed ALL	NCT00187083	Acute Lymphobla...	Topotecan, dexa... E. coli Asparag... erwinia asparag... fludarabine, me... idarubicin, eto... chemotherapy, i...	- 18 Years	St. Jude Children's Research Hospital
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents	NCT03020030	Acute Lymphobla...	Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine	1 Year - 21 Years	Dana-Farber Cancer Institute
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax	NCT05192889	Refractory Acut... Relapsed Acute ...	Venetoclax Navitoclax Dexamethasone Vincristine Calaspargase Pe... Dasatinib Cytarabine Blinatumomab Methotrexate Mercaptopurine Cyclophosphamid... Etoposide Leucovorin Intrathecal Tri... Pegaspargase Erwinia asparag... Radiation	4 Years - 30 Years	St. Jude Children's Research Hospital
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax	NCT05192889	Refractory Acut... Relapsed Acute ...	Venetoclax Navitoclax Dexamethasone Vincristine Calaspargase Pe... Dasatinib Cytarabine Blinatumomab Methotrexate Mercaptopurine Cyclophosphamid... Etoposide Leucovorin Intrathecal Tri... Pegaspargase Erwinia asparag... Radiation	4 Years - 30 Years	St. Jude Children's Research Hospital
Venetoclax Basket Trial for High Risk Hematologic Malignancies	NCT05292664	Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ...	Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag...	1 Year - 40 Years	Dana-Farber Cancer Institute

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: